Bluefin Capital Management, LLC Aurinia Pharmaceuticals Inc. Call Options Transaction History

Bluefin Capital Management, LLC

  • $1.3 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$17.78 - $33.08 $5,334 - $9,924
-300 Reduced 0.64%
46,700 $381,000
Q3 2021

Nov 15, 2021
SELL
$10.93 - $23.55 $10,930 - $23,550
-1,000 Reduced 2.08%
47,000 $432,000
Q2 2021

Aug 16, 2021
BUY
$10.0 - $14.52 $480,000 - $696,960
48,000 New
48,000 $146,000

Others Institutions Holding AUPH

# of Institutions
210
Shares Held
58.1M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.13B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Bluefin Capital Management, LLC Portfolio

Follow Bluefin Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluefin Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email